Genpact (G) Stock Drops 29%: Is a Recovery Near After 325 Days?

Genpact Limited Slides 29% From Its Peak: What History Shows About This Red Zone Entry

G/" class="text-primary hover:underline">Genpact Limited (G) has officially entered the red zone, signaling a period of significant technical stress that separates it from many of its peers in the professional services and IT consulting sector. While the broader market has shown resilience, Genpact's transition from a yellow zone to a Drawdown Severity Score™ of 5.7 suggests a deeper correction is underway. This move reflects a specific decoupling from the stability seen in larger consulting firms, placing the stock in a high-severity category that we have not seen for this ticker in several months.

Genpact Crosses Into High Severity Territory

The current Drawdown Severity Score™ for Genpact stands at 5.7, which our data classifies as "Strong" and places the stock firmly in the red zone. This metric is a proprietary calculation that measures the intensity of a price decline relative to the asset's historical behavior. Moving from the yellow zone to the red zone indicates that the selling pressure has accelerated beyond standard market volatility.

As of today, Genpact is trading at $38.97, which represents a 29.0% decline from its all-time high of $54.92. This drawdown has persisted for 325 days, a duration that far exceeds the company's historical averages. Our data shows that across 93 total historical drawdown events, the average max drawdown for Genpact is typically only -5.3%.

The fact that the current decline is nearly six times the historical average explains why the Drawdown Severity Score™ has escalated so quickly. Investors are currently witnessing a prolonged period of underperformance that deviates sharply from the stock's usual recovery patterns.

Comparing Genpact to Historical Averages

To understand the current risk profile, we must look at how Genpact has behaved during previous periods of volatility. Historically, the average drawdown duration for this stock is 67 days. The current 325-day stretch indicates this is not a routine pullback but a fundamental shift in price action that has lasted nearly five times longer than a typical cycle.

Our data indicates that Genpact has experienced 93 distinct drawdown events throughout its trading history. Most of these were minor corrections that resolved quickly. However, the current 29.0% drop is approaching a threshold that the company has only crossed a handful of times since its inception.

When a stock enters the red zone with a severity score of 5.7, it often indicates that the market is repricing the asset based on new growth expectations or sector-wide headwinds. For Genpact, staying in this zone for an extended period would be a departure from its historical tendency to mean-revert much faster than the current 325-day window suggests.

What Happens When Genpact Drops This Far?

Historical context is vital for determining what happens next. Our data shows that Genpact has dropped by 40% or more only 3 times in its history. Because this has only happened 3 times, we must note the small sample size when analyzing these specific historical averages.

In those rare instances where the drawdown reached the 40% threshold, the average duration of the comparable drops was 823 days. This suggests a significant "bifurcation" in Genpact's recovery timelines: either the stock recovers quickly from small 5% dips, or it enters a multi-year stagnation phase if the decline deepens toward that 40% mark.

Currently, at a 29.0% drawdown, Genpact is in a "no man's land" between a standard correction and these historic 40%+ crashes. The Drawdown Severity Score™ of 5.7 reflects this tension. If the stock continues to slide toward the -40% level, history suggests the recovery could be measured in years rather than months.

Monitoring the Path to Recovery

For a stock in the red zone, the path to recovery is rarely a straight line. We look for a stabilization in the Drawdown Severity Score™ as the first sign that the selling climax has passed. A transition back into the yellow zone would require a sustained upward price movement that reduces the current 29.0% gap from the all-time high.

Investors often track the duration of the drawdown as closely as the percentage. At 325 days, Genpact is currently in one of its longest-running price depressions. In professional services, these long drawdowns can sometimes be attributed to multi-quarter sales cycles or shifts in corporate spending on digital transformation.

While we do not provide investment advice, our data shows that the 5.7 severity score is a critical level for this ticker. Historically, when Genpact maintains a high severity score for more than a few weeks, it tends to test the support levels established during those 3 previous major historical drops.

Key Metrics to Watch

To determine if the current red zone status is temporary or the start of a longer decline, we monitor three specific data points. First is the stability of the $38.97 price level, as further declines will push the Drawdown Severity Score™ toward the "Extreme" category. Second is the duration; if this drawdown exceeds 365 days, it becomes a statistically significant outlier for Genpact.

Finally, we observe the gap between the current price and the all-time high of $54.92. A 29.0% drawdown is significant, but it remains above the -40% threshold that historically leads to the 823-day recovery cycles mentioned earlier. Keeping the decline within the current range is essential for a faster return to the green zone.

We will continue to monitor Genpact's proprietary data to see if the selling pressure abates or if the stock is headed for its fourth historical drop of 40% or more.